Overview

Ibuprofen in Sepsis Study

Status:
Completed

Trial end date:
1995-07-01

Target enrollment:

Participant gender:

Summary

To determine the effects of ibuprofen on mortality, development and reversal of shock, and adult respiratory distress syndrome, and on Lung Parenchymal Injury Score in adult patients with serious infection.

Phase:

Phase 3

Details

Lead Sponsor:

Vanderbilt University
Vanderbilt University Medical Center

Collaborator:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Ibuprofen